CTRI Number |
CTRI/2023/05/053279 [Registered on: 31/05/2023] Trial Registered Prospectively |
Last Modified On: |
28/08/2023 |
Post Graduate Thesis |
No |
Type of Trial |
PMS |
Type of Study
|
Medical Device |
Study Design |
Single Arm Study |
Public Title of Study
|
Post-Market Clinical Data Analysis With Skanrays Defibrillators (Clinical study to record the safety and performance data of Skanrays Defibrillators in real world scenario) |
Scientific Title of Study
|
A prospective, post-market clinical data analysis in patients undergoing cardioversion or
defibrillation using Skanrays Defibrillators |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
3-18-010-0139-44 Version 01 28 October 2022 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Manjappa Mahadevappa |
Designation |
Associate Professor |
Affiliation |
JSS Hospital |
Address |
Department of Cardiology JSS Hospital Mysuru
Mysore KARNATAKA 570004 India |
Phone |
7899584676 |
Fax |
|
Email |
manjappam@jssuni.edu.in |
|
Details of Contact Person Scientific Query
|
Name |
Dr Manjappa Mahadevappa |
Designation |
Associate Professor |
Affiliation |
JSS Hospital |
Address |
Department of Cardiology JSS Hospital Mysuru
KARNATAKA 570004 India |
Phone |
7899584676 |
Fax |
|
Email |
manjappam@jssuni.edu.in |
|
Details of Contact Person Public Query
|
Name |
Vasundhara R |
Designation |
Head Regulatory Affairs |
Affiliation |
Skanray Technologies Limited |
Address |
Skanray Technologies Limited Plot 15 16 17 Hebbal Industrial Area Mysore
Mysore KARNATAKA 570016 India |
Phone |
9844761818 |
Fax |
|
Email |
vasundhara.r@skanray.com |
|
Source of Monetary or Material Support
|
Skanray Technologies Limited Mysuru |
|
Primary Sponsor
|
Name |
Skanray Technologies Limited |
Address |
Plot 15 16 17 Hebbal Industrial Area Mysore |
Type of Sponsor |
Other [Medical Device Manufacturer] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Manjappa Mahadevappa |
JSS Hospital |
Department of Cardiology 3rd Floor JSS Hospital Mahatma Gandhi Road
Mysuru Mysore KARNATAKA |
7899584676
manjappam@jssuni.edu.in |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee JSS Medical College |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: I462||Cardiac arrest due to underlying cardiac condition, (2) ICD-10 Condition: I468||Cardiac arrest due to other underlying condition, (3) ICD-10 Condition: I469||Cardiac arrest, cause unspecified, (4) ICD-10 Condition: I480||Paroxysmal atrial fibrillation, (5) ICD-10 Condition: I481||Persistent atrial fibrillation, (6) ICD-10 Condition: I482||Chronic atrial fibrillation, (7) ICD-10 Condition: I489||Unspecified atrial fibrillation and atrial flutter, (8) ICD-10 Condition: R001||Bradycardia, unspecified, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Cardioversion |
Synchronized cardioversion |
Intervention |
Defibrillation |
External defibrillation |
Intervention |
Pacing |
Transcutaneous pacing |
|
Inclusion Criteria
|
Age From |
1.00 Year(s) |
Age To |
99.00 Year(s) |
Gender |
Both |
Details |
Data from the subject that meets the below-mentioned criteria shall be collected.
â— Patients with indications for defibrillation/cardioversion/pacing.
â— Male and female subjects who weigh above 10 kg. |
|
ExclusionCriteria |
Details |
â— Unsafe conditions or surroundings for the use of Direct Current
â— Contraindications for defibrillation
A A responsive patient with spontaneous breathing and a palpable pulse.
B Asystole or pulseless electrical activity PEA
â— Contraindications for cardioversion - arrhythmias due to enhanced automaticity, such as
digitalis toxicity of digitalis-associated tachycardia, sinus tachycardia, multifocal atrial
tachycardia and junctional tachycardia. Catecholamine-induced arrhythmia having a
homogeneous depolarization state Eg CPVT, shall be excluded.
â— Contraindications for pacing - asymptomatic subjects with a reasonably stable rhythm. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
To collect clinical data of patients undergoing defibrillation, cardioversion or pacing using
Skanrays Defibrillators. |
Within 1 day. |
|
Secondary Outcome
|
Outcome |
TimePoints |
To collect the following data with the use of Skanray defibrillators
a. Clinical feedback from the investigator.
b. Vital physiological parameters (including ECG, NIBP, SPO2) as measured by Skanrays
Defibrillators.
c. Feedback from the user reflecting the ease of defibrillation, cardioversion, pacing and
overall usability.
d. The evidence pertaining to defibrillation, cardioversion, and pacing in the given subject. |
Within 7 days |
|
Target Sample Size
|
Total Sample Size="65" Sample Size from India="65"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Post Marketing Surveillance |
Date of First Enrollment (India)
|
08/06/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
Not Applicable |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Skanray’s Defibrillators are portable external defibrillator with manual or semi automatic control along with pacing and monitoring of ECG, SpO2 (optional) and NiBP (optional). It employs bi-phasic current or duration controlled shock waveform. The Skanray’s Defibrillators defibrillator / monitor is used for the treatment of life threatening cardiac dysrhythmias by qualified medical personnel familiarised in the operation of the device and qualified by training in basic life support, advanced cardiac life support, or defibrillation, in a professional healthcare facility under controlled environment. Indicated for manual defibrillation therapy, semi-AED therapy and pacing therapy. This device is approved by European CE and CDSCO (DCGI). |